The UVA/PADOVA Type 1 Diabetes Simulator

Chiara Dalla Man, Francesco Micheletto, Dayu Lv, +3

Journal of Diabetes Science and Technology

Glucagon KineticsArtificial PancreasObesityMetabolic SyndromeBody Composition +15

The UVA/Padova Type 1 Diabetes Simulator Goes From Single Meal to Single Day

R. Visentin, Enrique Campos-Náñez, Michele Schiavon, +6

Journal of Diabetes Science and Technology

Continuous Glucose Monitoring and Insulin Informed Advisory System with Automated Titration and Dosing of Insulin Reduces Glucose Variability in Type 1 Diabetes Mellitus

Marc D. Breton, Stephen D. Patek, Dayu Lv, +11

Diabetes Technology & Therapeutics

Twelve-Week 24/7 Ambulatory Artificial Pancreas With Weekly Adaptation of Insulin Delivery Settings: Effect on Hemoglobin A1c and Hypoglycemia

Eyal Dassau, Jordan E. Pinsker, Yogish C. Kudva, +25

Diabetes Care

Adjustment of Open-Loop Settings to Improve Closed-Loop Results in Type 1 Diabetes: A Multicenter Randomized Trial

Eyal Dassau, Sue A. Brown, Ananda Basu, +21

The Journal of Clinical Endocrinology & Metabolism

Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system

José Garcia‐Tirado, Dayu Lv, John P. Corbett, +2

Computer Methods and Programs in Biomedicine

NutritionSilico ComparisonGastroenterologyPancreatic SurgeryPancreas Transplantation +4

Pharmacokinetics Modeling of Exogenous Glucagon in Type 1 Diabetes Mellitus Patients

Dayu Lv, Marc D. Breton, Leon S. Farhy

Diabetes Technology & Therapeutics

Determination of Henry’s law constant and the diffusion and polytropic coefficients of air in aviation fuel

Patrick F. Dunn, Flint O. Thomas, James Buckingham Leighton, +1

Fuel

Polytropic CoefficientsEngineeringAerospace EngineeringCombustion ScienceGas Dynamic +4

Pharmacokinetic Model of the Transport of Fast-Acting Insulin From the Subcutaneous and Intradermal Spaces to Blood

Dayu Lv, Sandip Kulkarni, Alice Chan, +5

Journal of Diabetes Science and Technology

Vivo Insulin TransportEngineeringIntradermal SpacesBiomedical EngineeringArtificial Pancreas +18

Retrospective Optimization of Daily Insulin Therapy Parameters: Control Subject to a Regenerative Disturbance Process**This material is based upon work supported in part by the National Institutes of Health under Grant No. NIH/NIDDK R01DK051562. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the author(s) and do not necessarily reflect the views of the sponsors. S. D. Patek and M. D. Breton disclose equity interest in TypeZero Technologies, Inc.

Stephen D. Patek, Dayu Lv, Enrique Campos-Náñez, +1

IFAC-PapersOnLine